News Center
With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.
31
2023
-
08
The central media theme communication event went to Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical!
Classification：
News
On August 29, the "Central Media High-Quality Development Theme Communication Activity" participated by more than ten media including People's Daily, Xinhua News Agency, Guangming Daily, etc., visited Shandong Keyuan Pharmaceutical Co., Ltd. (stock code 301281.SZ), and went in-depth Understand the synergistic advantages of the company's development of "integration of raw materials and preparations, integration of excipients and preparations". Zhang Danqing, director of the Propaganda Department of the Party Committee of Luxin Group, and his party, and relevant persons in charge of Keyuan Pharmaceuticals participated in the event.
In the exhibition hall of Linuo Group, the central media delegation learned in detail about the development history and core advantages of Keyuan Pharmaceutical and its subsidiary Linuo Pharmaceutical. Keyuan Pharmaceutical is a leading enterprise in the subdivision of raw material medicine in China. Its core products have passed the official drug administration certification of many countries and exported to many countries and regions in Europe, North America, Asia, South America and Africa.
Afterwards, the central media team arrived at the Panama Business Center for a discussion. Luxin Group is a strategic partner of Keyuan Pharmaceuticals, providing strong trust and support in the company's high-quality development process, and the attention and reports of media friends have provided a good public opinion environment for the company's development. Keyuan Pharmaceuticals was successfully listed on the Shenzhen Stock Exchange on April 4, 2023, and has entered a stage of rapid development supported by capital. The company's strategic goals are clear, the tactics are advanced vigorously, and the development trend continues to improve.
In the future, Keyuan Pharmaceutical will adopt a more open attitude, sincerely cooperate and develop hand in hand with friends from all walks of life, so that high-quality drugs can benefit more patients and give back to the society with more excellent results.
Related news
2023-08-31
On August 29, the "Central Media High-Quality Development Theme Communication Activity" participated by more than ten media including People's Daily, Xinhua News Agency, Guangming Daily, etc., visited Shandong Keyuan Pharmaceutical Co., Ltd.
2023-08-30
Quality is the core competitiveness related to the survival of an enterprise. Strengthening the construction of a quality enterprise is an effective measure for Keyuan Pharmaceutical (stock code: 301281.SZ) to implement the concept of "lean production and quality first". The company continues to improve the quality system and strengthen training.
2023-08-24
In order to thoroughly implement the theme spirit of "Quality is in my hands and customers are in my heart" for Keyuan Pharmaceutical (stock code: 301281.SZ) Quality Month in 2023, and empower and improve quality management, the Quality Management Center and Human Resources Center held a meeting on August 23 The joint organization carried out a one-day QC group activity training meeting.
2023-08-23
In order to better carry forward the corporate culture spirit of family, one table meal, one heart, one effort, enhance the cohesion and sense of belonging of all employees, enrich the spiritual and cultural life of employees, and let the majority of employees feel that Keyuan Pharmaceutical (stock code: 301281.SZ) The warmth of the big family.
ADD：#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China